Quanticate is Bronze Sponsor at this year's 31st Pharmacovigilance Conference
January 17, 2023
Quanticate is Bronze Sponsor at this year's 31st Pharmacovigilance Conference, 1st - 2nd February.
With more than 40 speakers and 100+ Pharmacovigilance and Safety Experts, this event is a great opportunity to gain insights on the latest developments in pharmacovigilance, drug safety & risk management.
You can discover the full agenda and register to the conference by clicking here.
Our representatives, Fabien Du Fraisse and Ankit Sharma, will be there to further discuss and answer any questions on our quality-driven Pharmacovigilance services. Visit our booth to see how Quanticate can support you in achieving your 2023 goals.
Alternatively, if you would like to speak with our team now, don't hesitate to get in touch with us.
Quanticate is one of the world's largest global data-focused clinical research organizations (CROs) with a primary focus on data collection and validation, statistical analysis, and clinical trial reporting.
With the launch of QVigilance in 2018, Quanticate focused even more on providing comprehensive pharmacovigilance (PV) and risk management services for Sponsors of clinical trials and Marketing Authorization Holders.
Quanticate's reach is global, with offices across three continents, and the solutions offered are customer-focused, from fixed cost or functional service provider (FSP) models to consultancy.
By offering high-quality, value-added flexible solutions that meet current and future development needs, Quanticate has become the trusted supplier of choice for many companies, from niche biotechnology and device companies to top-tier pharmaceutical giants.